|
|
Post by nylefty on Jul 29, 2016 13:43:41 GMT -5
No, that's the point - they are correcting errors... one of the reasons retention is not peak yet is 30 day supply... he is masking cost reduction to true supply... or truer supply - bc the fda was so innaccurate this concept is in play and will determine once settled... good business - accomplishment. Who are you responding to? I have no way of knowing what "the point" is. Please use the quote button so we can see what you're reacting to. |
|
|
|
Post by figglebird on Jul 29, 2016 13:47:41 GMT -5
Someone about four messages earlier from my original had in error assumed refills would stagnate bc of cost adjustment w respect to titration. It was in my opinion such an important and profound misread etc that I wanted to see if anyone else recognized - thus I did not quote.
|
|
|
|
Post by akemp3000 on Jul 29, 2016 16:47:52 GMT -5
I've been thinking about the potential Sanofi cash or settlement issue. Could be that Matt will remain silent on this subject until scripts rise. There would be no better proof that Sanofi sandbagged Afrezza than to ramp up better sales going it alone with a smaller but more focused sales force!
|
|
|
|
Post by daduke38 on Jul 29, 2016 17:28:49 GMT -5
I've been thinking about the potential Sanofi cash or settlement issue. Could be that Matt will remain silent on this subject until scripts rise. There would be no better proof that Sanofi sandbagged Afrezza than to ramp up better sales going it alone with a smaller but more focused sales force! First off, Welcome over! I think that is exactly what Matt is doing. In fact, I think he has to. Scripts are everything going forward on so many levels. Just hoping we have actually bottomed. My gut is MNKD has. But my gut feeling and MNKD hasn't always aligned  |
|
|
|
Post by buyitonsale on Jul 30, 2016 0:22:05 GMT -5
Not a single genius here can commit to "I think they can do it" or "no way, they can not".
It's uncomfortable to be wrong, isn't it...
|
|
|
|
Post by peppy on Jul 30, 2016 7:49:22 GMT -5
From one thread to another. We should have money to get through Q1 2017 the thread title.
The insulin put; Excerpt 10-Q Filing:
"Under the terms of the Sanofi Supply Agreement, in the event that Sanofi terminates the Sanofi License Agreement for various reasons (including the reasons cited in its notice of termination to the Company), then upon written notice from the Company within 30 days following the termination date, Sanofi is obligated to purchase up to $50 million of the Company’s insulin inventory as a percentage of each lot received or receivable by the Company (the “Insulin Put”). On April 14, 2016, the Company provided Sanofi with written notice that it was exercising the Insulin Put. The Company and Sanofi are currently discussing the schedule of purchases and deliveries pursuant to the Insulin Put."
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- The "insulin put" says that Mannkind can redirect up to the lesser of 65% or $50 million of the Amphistar insulin commitment to Sanofi. There is no money for Mannkind in this since it's a pass-through transaction. The clause is there to mitigate Mannkind's exposure to the Amphistar contract in exactly the sort of situation we are in now.
------------------------------------------------------------------------------------------------------------------------------------------------------------------ Didn't Mannkind already take a loss on additionally purchased Amphistar insulin?
|
|
|
|
Post by slugworth008 on Jul 31, 2016 9:40:32 GMT -5
I've been thinking about the potential Sanofi cash or settlement issue. Could be that Matt will remain silent on this subject until scripts rise. There would be no better proof that Sanofi sandbagged Afrezza than to ramp up better sales going it alone with a smaller but more focused sales force! Very interesting pontification - and IMO you would think that would be tough for SNY to defend in court. I'm down with anything that nails SNY. |
|
|
|
Post by agedhippie on Jul 31, 2016 11:30:36 GMT -5
From one thread to another. We should have money to get through Q1 2017 the thread title.
The insulin put; Excerpt 10-Q Filing:
"Under the terms of the Sanofi Supply Agreement, in the event that Sanofi terminates the Sanofi License Agreement for various reasons (including the reasons cited in its notice of termination to the Company), then upon written notice from the Company within 30 days following the termination date, Sanofi is obligated to purchase up to $50 million of the Company’s insulin inventory as a percentage of each lot received or receivable by the Company (the “Insulin Put”). On April 14, 2016, the Company provided Sanofi with written notice that it was exercising the Insulin Put. The Company and Sanofi are currently discussing the schedule of purchases and deliveries pursuant to the Insulin Put."
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- The "insulin put" says that Mannkind can redirect up to the lesser of 65% or $50 million of the Amphistar insulin commitment to Sanofi. There is no money for Mannkind in this since it's a pass-through transaction. The clause is there to mitigate Mannkind's exposure to the Amphistar contract in exactly the sort of situation we are in now.
------------------------------------------------------------------------------------------------------------------------------------------------------------------ Didn't Mannkind already take a loss on additionally purchased Amphistar insulin?
They probably took a loss on their portion of the insulin which would be 35% of the insulin. The remaining 65% will have been paid for by Sanofi. Termination happened on April 4th and that is when the 'Put" could be exercise which Mannkind duly did. From that point onwards Sanofi had to take 65% of the insulin up to the value of $50 million. |
|
|
|
Post by cm5 on Jul 31, 2016 11:47:59 GMT -5
|
|
